Skip to main content

Table 5 Effect of non-haplogroup determining mtSNPs on breast cancer, colorectal cancer and thyroid cancer

From: Cancer type-specific modulation of mitochondrial haplogroups in breast, colorectal and thyroid cancer

  CCS of breast cancer   CCS of colorectal cancer   CCS of thyroid cancer  
mtSNPs Controls Cases OR P value Controls Cases OR P value Controls Cases OR P value
  (N = 114) (N = 104) (95%CI)   (N = 125) (N = 108) (95%CI)   (N = 138) (N = 100) (95%CI)  
T16140C 11 7 0.68(0.25-1.81) 0.434 13 14 1.28(0.58-2.87) 0.542 13 7 0.72(0.28-1.89) 0.507
A16182C 11 18 1.96(0.88-4.37) 0.096 18 11 0.67(0.30-1.50) 0.331 15 13 1.23(0.56-2.71) 0.615
A16183C 29 28 1.08(0.59-1.98) 0.803 36 22 0.63(0.34-1.16) 0.138 32 25 1.10(0.61-2.01) 0.747
T16189C 38 35 1.01(0.58-1.78) 0.960 42 36 0.99(0.57-1.71) 0.966 46 26 0.70(0.40-1.24) 0.224
T16217C 16 11 0.72(0.32-1.64) 0.439 17 9 0.58(0.25-1.36) 0.203 19 9 0.62(0.27-1.43) 0.260
C16223T 69 68 1.23(0.71-2.14) 0.458 73 66 1.12(0.66-1.89) 0.674 83 62 1.08(0.64-1.83) 0.772
T16298C 10 12 1.36(0.56-3.29) 0.498 10 14 1.71(0.73-4.03) 0.214 12 6 0.67(0.24-1.85) 0.438
T16304C 11 13 1.33(0.57-3.13) 0.502 23 14 0.66(0.32-1.36) 0.257 28 13 0.59(0.29-1.20) 0.142
T16311C 20 17 0.92(0.45-1.87) 0.814 23 13 0.61(0.29-1.27) 0.180 19 9 0.62(0.27-1.43) 0.260
G16319A 15 13 0.94(0.43-2.09) 0.885 11 18 2.07(0.93-4.61) 0.070 17 16 1.36(0.65-2.83) 0.417
T146C 16 17 1.20(0.57-2.51) 0.634 13 17 1.61(0.74-3.49) 0.225 20 10 0.66(0.29-1.47) 0.303
C150T 28 33 1.43(0.79-2.59) 0.239 33 25 0.84(0.46-1.53) 0.567 33 22 0.90(0.49-1.66) 0.730
T152C 20 23 1.34(0.68-2.61) 0.397 27 26 1.15(0.62-2.13) 0.653 33 31 1.43(0.80-2.55) 0.224
249delA 20 19 1.05(0.53-2.10) 0.889 25 23 1.08(0.57-2.04) 0.807 31 13 0.52(0.25-1.05) 0.063
524delAC 42 27 0.60(0.34-1.07) 0.084 43 33 0.84(0.48-1.46) 0.532 52 42 1.20(0.71-2.0) 0.501
  1. P values were estimated by "chi-square test"; (*) indicated statistical significant (P < 0.05). OR indicates odds ratio; 95% CI, 95% confidence interval.3